BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 38247727)

  • 1. Diagnosing Cutaneous Melanocytic Tumors in the Molecular Era: Updates and Review of Literature.
    Huang C; Lau TW; Smoller BR
    Dermatopathology (Basel); 2024 Jan; 11(1):26-51. PubMed ID: 38247727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated Genomic Classification of Melanocytic Tumors of the Central Nervous System Using Mutation Analysis, Copy Number Alterations, and DNA Methylation Profiling.
    Griewank KG; Koelsche C; van de Nes JAP; Schrimpf D; Gessi M; Möller I; Sucker A; Scolyer RA; Buckland ME; Murali R; Pietsch T; von Deimling A; Schadendorf D
    Clin Cancer Res; 2018 Sep; 24(18):4494-4504. PubMed ID: 29891723
    [No Abstract]   [Full Text] [Related]  

  • 3. PRAME Expression in Melanocytic Tumors.
    Lezcano C; Jungbluth AA; Nehal KS; Hollmann TJ; Busam KJ
    Am J Surg Pathol; 2018 Nov; 42(11):1456-1465. PubMed ID: 30045064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cytogenetics of cutaneous melanocytic lesions - diagnostic, prognostic and therapeutic aspects.
    Blokx WA; van Dijk MC; Ruiter DJ
    Histopathology; 2010 Jan; 56(1):121-32. PubMed ID: 20055910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
    Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
    J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary Undifferentiated/Dedifferentiated Cutaneous Melanomas-A Review on Histological, Immunohistochemical, and Molecular Features with Emphasis on Prognosis and Treatment.
    Țăpoi DA; Gheorghișan-Gălățeanu AA; Dumitru AV; Ciongariu AM; Furtunescu AR; Marin A; Costache M
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Catenin nuclear expression discriminates deep penetrating nevi from other cutaneous melanocytic tumors.
    de la Fouchardière A; Caillot C; Jacquemus J; Durieux E; Houlier A; Haddad V; Pissaloux D
    Virchows Arch; 2019 May; 474(5):539-550. PubMed ID: 30756182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic utility of combining PRAME and HMB-45 stains in primary melanocytic tumors.
    Rasic D; Korsgaard N; Marcussen N; Precht Jensen EM
    Ann Diagn Pathol; 2023 Dec; 67():152211. PubMed ID: 37717457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of cyclooxygenase-2 (COX-2) in oral nevi and melanoma.
    de Souza do Nascimento J; Carlos R; Delgado-Azañero W; Mosqueda Taylor A; de Almeida OP; Romañach MJ; de Andrade BA
    J Oral Pathol Med; 2016 Jul; 45(6):440-3. PubMed ID: 26608958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular testing for melanocytic tumors: a practical update.
    Andea AA
    Histopathology; 2022 Jan; 80(1):150-165. PubMed ID: 34958511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microphthalmia transcription factor expression in cutaneous benign, malignant melanocytic, and nonmelanocytic tumors.
    King R; Googe PB; Weilbaecher KN; Mihm MC; Fisher DE
    Am J Surg Pathol; 2001 Jan; 25(1):51-7. PubMed ID: 11145251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential diagnostic utility of PRAME and p16 immunohistochemistry in melanocytic nevi and malignant melanoma.
    Bahmad HF; Oh KS; Alexis J
    J Cutan Pathol; 2023 Aug; 50(8):763-772. PubMed ID: 37114299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma.
    Busam KJ; Chen YT; Old LJ; Stockert E; Iversen K; Coplan KA; Rosai J; Barnhill RL; Jungbluth AA
    Am J Surg Pathol; 1998 Aug; 22(8):976-82. PubMed ID: 9706977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E-Cadherin Expression in Canine Melanocytic Tumors: Histological, Immunohistochemical, and Survival Analysis.
    Silvestri S; Porcellato I; Mechelli L; Menchetti L; Iussich S; De Maria R; Sforna M; Bongiovanni L; Brachelente C
    Vet Pathol; 2020 Sep; 57(5):608-619. PubMed ID: 32578507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemistry in melanocytic lesions: Updates with a practical review for pathologists.
    Saleem A; Narala S; Raghavan SS
    Semin Diagn Pathol; 2022 Jul; 39(4):239-247. PubMed ID: 35016807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Black and Brown Oro-facial Mucocutaneous Neoplasms.
    Natarajan E
    Head Neck Pathol; 2019 Mar; 13(1):56-70. PubMed ID: 30693458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathologic classification and prognostic factors of melanoma: a 2021 update.
    Bobos M
    Ital J Dermatol Venerol; 2021 Jun; 156(3):300-321. PubMed ID: 33982546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate of Immunohistochemistry Utilization in the Diagnosis of Cutaneous Melanocytic Lesions.
    Chen TC; Hitchcock MG
    Am J Dermatopathol; 2021 Dec; 43(12):e146-e148. PubMed ID: 33795556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermoscopy, with and without visual inspection, for diagnosing melanoma in adults.
    Dinnes J; Deeks JJ; Chuchu N; Ferrante di Ruffano L; Matin RN; Thomson DR; Wong KY; Aldridge RB; Abbott R; Fawzy M; Bayliss SE; Grainge MJ; Takwoingi Y; Davenport C; Godfrey K; Walter FM; Williams HC;
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011902. PubMed ID: 30521682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanocytic precursors of cutaneous melanoma. Estimated risks and guidelines for management.
    Rhodes AR
    Med Clin North Am; 1986 Jan; 70(1):3-37. PubMed ID: 3510347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.